Leland Gershell

Dec 23, 2025

Leland Gershell rated SPRB as Outperform on Dec 23, 2025, setting a price target of 283. Shares have remained stable near 82.82, leaving the 283 target still in play.

Dec 23, 2025

On Dec 23, 2025, AARD was given a Outperform rating by Leland Gershell, with a target price of 35. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

Dec 08, 2025

CAPR received a Outperform rating from Leland Gershell on Dec 08, 2025, aiming for 54. Price action was muted, as shares hovered around 29.5 despite the bullish outlook.

Nov 14, 2025

On Nov 14, 2025, Leland Gershell published a Outperform outlook on TRVI, with a target of 24. Shares gained 12.05%, underscoring the accuracy of the bullish outlook toward 24.

Nov 12, 2025

Leland Gershell on Nov 12, 2025 assigned ENGN a Outperform rating, with a price target of 33. The recommendation remains pending validation as shares consolidate around 8.77.

Nov 07, 2025

On Nov 07, 2025, Leland Gershell reaffirmed XERS with a Outperform rating, targeting 18. Market indecision has kept the 18 target in a holding pattern.

Oct 21, 2025

VRDN was rated Outperform by Leland Gershell on Oct 21, 2025, with a price objective of 36. A bullish response from the market helped close the gap of 3.53 to the target.

Sep 30, 2025

On Sep 30, 2025, Leland Gershell initiated coverage on CRNX with a Outperform rating and target of 87. The stock’s climb of 18.22% since the call highlights the foresight in the rating.

Sep 03, 2025

Leland Gershell issued a Outperform recommendation for TECX on Sep 03, 2025, price target set at 80. Investors following the Buy call captured upside momentum, with shares now at 21.41.

Aug 07, 2025

On Aug 07, 2025, SLNO was evaluated by Leland Gershell, who gave a Outperform rating and target of 110. Investors saw limited payoff as shares fell short of the 110 target.

Aug 06, 2025

Leland Gershell rated BBIO as Outperform on Aug 06, 2025, setting a price target of 61. The call has proven timely, with shares rising 72.04% toward the price target of 61.

Aug 04, 2025

On Aug 04, 2025, ALNY was given a Outperform rating by Leland Gershell, with a target price of 490. The stock traded sideways with a -2.82% move, keeping the bullish thesis unresolved.

Jul 31, 2025

LXEO received a Outperform rating from Leland Gershell on Jul 31, 2025, aiming for 20. Momentum has favored the Buy call, with shares climbing from 10.63 to 10.63, rewarding those who trusted the recommendation.

Jul 10, 2025

On Jul 10, 2025, Leland Gershell published a Outperform outlook on RYTM, with a target of 110. Shares gained 26.77%, underscoring the accuracy of the bullish outlook toward 110.

Jun 13, 2025

Leland Gershell on Jun 13, 2025 assigned ASND a Outperform rating, with a price target of 224. The Buy call aligned well with market performance, producing a gain of 22.62%.

Jun 06, 2025

On Jun 06, 2025, Leland Gershell reaffirmed CLYM with a Outperform rating, targeting 10. Market indecision has kept the 10 target in a holding pattern.

Jun 03, 2025

URGN was rated Outperform by Leland Gershell on Jun 03, 2025, with a price objective of 10. A bullish response from the market helped close the gap of -13.58 to the target.

Mar 24, 2025

On Mar 24, 2025, Leland Gershell initiated coverage on QNCX with a Outperform rating and target of 10. The stock’s climb of 160.71% since the call highlights the foresight in the rating.

Feb 28, 2025

Leland Gershell issued a Outperform recommendation for ARGX on Feb 28, 2025, price target set at 704. Investors following the Buy call captured upside momentum, with shares now at 852.04.

Feb 24, 2025

On Feb 24, 2025, BMRN was evaluated by Leland Gershell, who gave a Outperform rating and target of 98. Investors saw limited payoff as shares fell short of the 98 target.

Oct 09, 2024

Leland Gershell rated IMVT as Outperform on Oct 09, 2024, setting a price target of 53. The stock has underperformed, dropping 8.26% despite the bullish target of 53.

Oct 03, 2024

On Oct 03, 2024, LGND was given a Outperform rating by Leland Gershell, with a target price of 135. The stock rallied 93.62% after the rating, narrowing the gap to the target of 135 and validating the bullish stance.

Oct 03, 2024

DNTH received a Outperform rating from Leland Gershell on Oct 03, 2024, aiming for 48. Momentum has favored the Buy call, with shares climbing from 43.77 to 43.77, rewarding those who trusted the recommendation.

Sep 12, 2024

On Sep 12, 2024, Leland Gershell published a Outperform outlook on SABS, with a target of 12. Shares gained 38.63%, underscoring the accuracy of the bullish outlook toward 12.

Sep 03, 2024

Leland Gershell on Sep 03, 2024 assigned NCNA a Outperform rating, with a price target of 25. The recommendation remains pending validation as shares consolidate around 3.41.

Aug 02, 2024

On Aug 02, 2024, Leland Gershell reaffirmed LUMO with a Outperform rating, targeting 13. The recommendation was supported by strong follow-through as the stock rose from 4.34 to 4.34.

Jul 10, 2024

CALC was rated Outperform by Leland Gershell on Jul 10, 2024, with a price objective of 20. A bullish response from the market helped close the gap of 13.77 to the target.